Cost analysis in thyroid cancer clinical trials: Toward value-based oncology care
The inclusion of cost analysis in thyroid cancer clinical trials is limited. Given rising cost pressures in modern healthcare systems, the low prevalence of cost endpoints and cost-effectiveness analyses underscores the need for increased awareness and investment in this domain.
Authors
- Carmen C. Solórzano (ORCID: https://orcid.org/0000-0002-0066-8591)
- James L. Rogers (ORCID: https://orcid.org/0000-0002-4790-5152)
- Angela Fahey
- Sebastian Henostroza
Institutions
- Vanderbilt University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- The American Journal of Surgery
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1016/j.amjsurg.2025.116772
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00